Recently, the 8th American Joint Committee on Cancer (AJCC) staging system incorporated biologic factors, including tumour grade, estrogen receptor (ER) status, progesterone receptor status, and human epidermal growth factor receptor 2 (HER2) status, into the traditional anatomic staging factors to develop the prognostic staging system4. This evidence concerns the gene ERBB2 and neoplasm.